Ditazole

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Chemical structure of Ditazole
Ditazole
Systematic (IUPAC) name
2,2'-(4,5-diphenyloxazol-2-ylazanediyl)diethanol
Identifiers
CAS number 18471-20-0
ATC code B01AC01
PubChem 29088
Chemical data
Formula C19H20N2O3 
Mol. mass 324.374 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

WikiDoc Resources for

Ditazole

Articles

Most recent articles on Ditazole

Most cited articles on Ditazole

Review articles on Ditazole

Articles on Ditazole in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ditazole

Images of Ditazole

Photos of Ditazole

Podcasts & MP3s on Ditazole

Videos on Ditazole

Evidence Based Medicine

Cochrane Collaboration on Ditazole

Bandolier on Ditazole

TRIP on Ditazole

Clinical Trials

Ongoing Trials on Ditazole at Clinical Trials.gov

Trial results on Ditazole

Clinical Trials on Ditazole at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ditazole

NICE Guidance on Ditazole

NHS PRODIGY Guidance

FDA on Ditazole

CDC on Ditazole

Books

Books on Ditazole

News

Ditazole in the news

Be alerted to news on Ditazole

News trends on Ditazole

Commentary

Blogs on Ditazole

Definitions

Definitions of Ditazole

Patient Resources / Community

Patient resources on Ditazole

Discussion groups on Ditazole

Patient Handouts on Ditazole

Directions to Hospitals Treating Ditazole

Risk calculators and risk factors for Ditazole

Healthcare Provider Resources

Symptoms of Ditazole

Causes & Risk Factors for Ditazole

Diagnostic studies for Ditazole

Treatment of Ditazole

Continuing Medical Education (CME)

CME Programs on Ditazole

International

Ditazole en Espanol

Ditazole en Francais

Businness

Ditazole in the Marketplace

Patents on Ditazole

Experimental / Informatics

List of terms related to Ditazole

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Ditazole is a platelet aggregation inhibitor.It is marketed in Spain and Portugal under the trade name Ageroplas.[1]

References

  • The Merck Index, 12th Edition. 3432
WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools